New Drugs Quiz, Early 2017
Test your knowledge of recent approvals that are significant for primary care.
The FDA has granted several new drug approvals and indications in the first quarter of 2017. Take this quick quiz to test your knowledge of the significant approvals for primary care.
Note: If you would like more information on any of the questions, a link to the original article, “Top 10 Primary Care Drugs Approved in Early 2017,” is provided on the last page of the quiz.
Question 1:
For more information on all questions and answers, please visit “Top 10 Primary Care Drugs Approved in Early 2017.”
Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD
June 11th 2025RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.
